Stephen Seim is stepping down as chief strategy officer of Amedisys Inc., effective March 5, under a mutual agreement with the company.
Amedisys said Seim's departure will constitute a termination without cause.
Amedisys chief strategy officer steps down
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Stephen Seim is stepping down as chief strategy officer of Amedisys Inc., effective March 5, under a mutual agreement with the company.
Amedisys said Seim's departure will constitute a termination without cause.